Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?

Recruiting

Early Phase 1

Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?

Sponsor:

University of Virginia

Code:

NCT04075149

Conditions

Polycystic Ovary Syndrome

Puberty Disorders

Ovulation Disorder

Eligibility Criteria

Sex: Female

Age: 13 - 19

Healthy Volunteers: Not accepted

Interventions

Spironolactone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by University of Virginia on 2023-10-27.